SPY753.48−0.83%QQQ679.67−1.55%BTC/USD72,514.31−1.91%DIA522.90−0.29%GLD359.56−1.54%TLT80.42−0.62%

AngioDynamics Inc

ANGONASDAQ

Trade with Public

$12.42

0.352.9%

Last update: Nov 11, 7:23 PM

Overview News Charts Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Options Stock Report

AngioDynamics (ANGO) Stock Price Target 2026

See analyst price targets, ratings and recent upgrades and downgrades for AngioDynamics (ANGO) stock.

Analyst Consensus — 6 Analysts

6Buy

# Analysts6

Latest Upgrades and Downgrades for AngioDynamics Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
—	HC Wainwright & Co.	Yi Chen	PT Cut	Buy	$19→$18
—	Canaccord Genuity	John Young	Maintained	Buy	$20
—	HC Wainwright & Co.	Yi Chen	PT Raise	Buy	$16→$19
—	Canaccord Genuity	John Young	PT Raise	Buy	$16→$20
—	Freedom Broker	Ilya Zubkov	Initiate	Buy	$16
—	Canaccord Genuity	John Young	PT Cut	Buy	$18→$16
—	Canaccord Genuity	William Plovanic	PT Raise	Buy	$17→$18
—	Lake Street	Frank Takkinen	Initiate	Buy	$24
—	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$16
—	Canaccord Genuity	William Plovanic	PT Raise	Buy	$15→$17
—	HC Wainwright & Co.	Yi Chen	PT Raise	Buy	$15→$16
—	HC Wainwright & Co.	Yi Chen	PT Raise	Buy	$14→$15
—	Canaccord Genuity	William Plovanic	PT Raise	Buy	$12→$15
—	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$14
—	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$14
—	Canaccord Genuity	William Plovanic	PT Cut	Buy	$13→$12
—	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$14
—	Canaccord Genuity	William Plovanic	PT Cut	Buy	$18→$13
—	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$14
—	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$14

AngioDynamics Inc

AngioDynamics (ANGO) Stock Price Target 2026

Latest Upgrades and Downgrades for AngioDynamics Stock

AngioDynamics (ANGO) Stock Price Target 2026

Latest Upgrades and Downgrades for AngioDynamics Stock

Analyst Ratings News

PRO
HC Wainwright & Co. Maintains Buy on AngioDynamics, Lowers Price Target to $18

PRO
HC Wainwright & Co. Maintains Buy on AngioDynamics, Raises Price Target to $19

PRO
Canaccord Genuity Maintains Buy on AngioDynamics, Raises Price Target to $20

PRO
Canaccord Genuity Maintains Buy on AngioDynamics, Lowers Price Target to $16

AngioDynamics Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

AngioDynamics Eyes Growth Despite Tariffs

People Also Watch

People Also Watch

Analyst Ratings News

PRO
HC Wainwright & Co. Maintains Buy on AngioDynamics, Lowers Price Target to $18

PRO
HC Wainwright & Co. Maintains Buy on AngioDynamics, Raises Price Target to $19

PRO
Canaccord Genuity Maintains Buy on AngioDynamics, Raises Price Target to $20

PRO
Canaccord Genuity Maintains Buy on AngioDynamics, Lowers Price Target to $16

AngioDynamics Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

AngioDynamics Eyes Growth Despite Tariffs

AngioDynamics Inc

AngioDynamics (ANGO) Stock Price Target 2026

Latest Upgrades and Downgrades for AngioDynamics Stock

AngioDynamics (ANGO) Stock Price Target 2026

Latest Upgrades and Downgrades for AngioDynamics Stock

Analyst Ratings News

PROHC Wainwright & Co. Maintains Buy on AngioDynamics, Lowers Price Target to $18

PROHC Wainwright & Co. Maintains Buy on AngioDynamics, Raises Price Target to $19

PROCanaccord Genuity Maintains Buy on AngioDynamics, Raises Price Target to $20

PROCanaccord Genuity Maintains Buy on AngioDynamics, Lowers Price Target to $16

AngioDynamics Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

AngioDynamics Eyes Growth Despite Tariffs

People Also Watch

People Also Watch

Analyst Ratings News

PROHC Wainwright & Co. Maintains Buy on AngioDynamics, Lowers Price Target to $18

PROHC Wainwright & Co. Maintains Buy on AngioDynamics, Raises Price Target to $19

PROCanaccord Genuity Maintains Buy on AngioDynamics, Raises Price Target to $20

PROCanaccord Genuity Maintains Buy on AngioDynamics, Lowers Price Target to $16

AngioDynamics Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

AngioDynamics Eyes Growth Despite Tariffs

PRO
HC Wainwright & Co. Maintains Buy on AngioDynamics, Lowers Price Target to $18

PRO
HC Wainwright & Co. Maintains Buy on AngioDynamics, Raises Price Target to $19

PRO
Canaccord Genuity Maintains Buy on AngioDynamics, Raises Price Target to $20

PRO
Canaccord Genuity Maintains Buy on AngioDynamics, Lowers Price Target to $16

PRO
HC Wainwright & Co. Maintains Buy on AngioDynamics, Lowers Price Target to $18

PRO
HC Wainwright & Co. Maintains Buy on AngioDynamics, Raises Price Target to $19

PRO
Canaccord Genuity Maintains Buy on AngioDynamics, Raises Price Target to $20

PRO
Canaccord Genuity Maintains Buy on AngioDynamics, Lowers Price Target to $16